Cargando…

Clinical Significance of Tumor Necrosis Factor-α Inhibitors in the Treatment of Sciatica: A Systematic Review and Meta-Analysis

BACKGROUND AND OBJECTIVE: Currently, no satisfactory treatment is available for sciatica caused by herniated discs and/or spinal stenosis. The objective of this study is to assess the value of tumor necrosis factor (TNF)-α inhibitors in the treatment of sciatica. METHODS: Without language restrictio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yun Fu, Chen, Ping You, Chang, Wei, Zhu, Fi Qi, Xu, Li Li, Wang, Song Lin, Chang, Li Ying, Luo, Jie, Liu, Guang Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106891/
https://www.ncbi.nlm.nih.gov/pubmed/25050851
http://dx.doi.org/10.1371/journal.pone.0103147
_version_ 1782327549701914624
author Wang, Yun Fu
Chen, Ping You
Chang, Wei
Zhu, Fi Qi
Xu, Li Li
Wang, Song Lin
Chang, Li Ying
Luo, Jie
Liu, Guang Jian
author_facet Wang, Yun Fu
Chen, Ping You
Chang, Wei
Zhu, Fi Qi
Xu, Li Li
Wang, Song Lin
Chang, Li Ying
Luo, Jie
Liu, Guang Jian
author_sort Wang, Yun Fu
collection PubMed
description BACKGROUND AND OBJECTIVE: Currently, no satisfactory treatment is available for sciatica caused by herniated discs and/or spinal stenosis. The objective of this study is to assess the value of tumor necrosis factor (TNF)-α inhibitors in the treatment of sciatica. METHODS: Without language restrictions, we searched PubMed, OVID, EMBASE, the Web of Science, the Clinical Trials Registers, the Cochrane Central Register of Controlled Trials and the China Academic Library and Information System. We then performed a systematic review and meta-analysis on the enrolled trials that met the inclusion criteria. RESULTS: Nine prospective randomized controlled trials (RCTs) and two before-after controlled trials involving 531 patients met our inclusion criteria and were included in this study. Our systematic assessment and meta-analysis demonstrated that in terms of the natural course of the disease, compared with the control condition, TNF-α inhibitors neither significantly relieved lower back and leg pain (both p>0.05) nor enhanced the proportion of patients who felt overall satisfaction (global perceived effect (satisfaction)) or were able to return to work (return to work) (combined endpoint; p>0.05) at the short-term, medium-term and long-term follow-ups. In addition, compared with the control condition, TNF-α inhibitors could reduce the risk ratio (RR) of discectomy or radicular block (combined endpoint; RR = 0.51, 95% CI 0.26 to 1.00, p = 0.049) at medium-term follow-up, but did not decrease RR at the short-term (RR = 0.64, 95% CI 0.17 to 2.40, p = 0.508) and long-term follow-ups (RR = 0.64, 95% CI 0.40 to 1.03, p = 0.065). CONCLUSION: The currently available evidence demonstrated that other than reducing the RR of discectomy or radicular block (combined endpoint) at medium-term follow-up, TNF-α inhibitors showed limited clinical value in the treatment of sciatica caused by herniated discs and/or spinal stenosis.
format Online
Article
Text
id pubmed-4106891
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41068912014-07-23 Clinical Significance of Tumor Necrosis Factor-α Inhibitors in the Treatment of Sciatica: A Systematic Review and Meta-Analysis Wang, Yun Fu Chen, Ping You Chang, Wei Zhu, Fi Qi Xu, Li Li Wang, Song Lin Chang, Li Ying Luo, Jie Liu, Guang Jian PLoS One Research Article BACKGROUND AND OBJECTIVE: Currently, no satisfactory treatment is available for sciatica caused by herniated discs and/or spinal stenosis. The objective of this study is to assess the value of tumor necrosis factor (TNF)-α inhibitors in the treatment of sciatica. METHODS: Without language restrictions, we searched PubMed, OVID, EMBASE, the Web of Science, the Clinical Trials Registers, the Cochrane Central Register of Controlled Trials and the China Academic Library and Information System. We then performed a systematic review and meta-analysis on the enrolled trials that met the inclusion criteria. RESULTS: Nine prospective randomized controlled trials (RCTs) and two before-after controlled trials involving 531 patients met our inclusion criteria and were included in this study. Our systematic assessment and meta-analysis demonstrated that in terms of the natural course of the disease, compared with the control condition, TNF-α inhibitors neither significantly relieved lower back and leg pain (both p>0.05) nor enhanced the proportion of patients who felt overall satisfaction (global perceived effect (satisfaction)) or were able to return to work (return to work) (combined endpoint; p>0.05) at the short-term, medium-term and long-term follow-ups. In addition, compared with the control condition, TNF-α inhibitors could reduce the risk ratio (RR) of discectomy or radicular block (combined endpoint; RR = 0.51, 95% CI 0.26 to 1.00, p = 0.049) at medium-term follow-up, but did not decrease RR at the short-term (RR = 0.64, 95% CI 0.17 to 2.40, p = 0.508) and long-term follow-ups (RR = 0.64, 95% CI 0.40 to 1.03, p = 0.065). CONCLUSION: The currently available evidence demonstrated that other than reducing the RR of discectomy or radicular block (combined endpoint) at medium-term follow-up, TNF-α inhibitors showed limited clinical value in the treatment of sciatica caused by herniated discs and/or spinal stenosis. Public Library of Science 2014-07-22 /pmc/articles/PMC4106891/ /pubmed/25050851 http://dx.doi.org/10.1371/journal.pone.0103147 Text en © 2014 Wang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wang, Yun Fu
Chen, Ping You
Chang, Wei
Zhu, Fi Qi
Xu, Li Li
Wang, Song Lin
Chang, Li Ying
Luo, Jie
Liu, Guang Jian
Clinical Significance of Tumor Necrosis Factor-α Inhibitors in the Treatment of Sciatica: A Systematic Review and Meta-Analysis
title Clinical Significance of Tumor Necrosis Factor-α Inhibitors in the Treatment of Sciatica: A Systematic Review and Meta-Analysis
title_full Clinical Significance of Tumor Necrosis Factor-α Inhibitors in the Treatment of Sciatica: A Systematic Review and Meta-Analysis
title_fullStr Clinical Significance of Tumor Necrosis Factor-α Inhibitors in the Treatment of Sciatica: A Systematic Review and Meta-Analysis
title_full_unstemmed Clinical Significance of Tumor Necrosis Factor-α Inhibitors in the Treatment of Sciatica: A Systematic Review and Meta-Analysis
title_short Clinical Significance of Tumor Necrosis Factor-α Inhibitors in the Treatment of Sciatica: A Systematic Review and Meta-Analysis
title_sort clinical significance of tumor necrosis factor-α inhibitors in the treatment of sciatica: a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106891/
https://www.ncbi.nlm.nih.gov/pubmed/25050851
http://dx.doi.org/10.1371/journal.pone.0103147
work_keys_str_mv AT wangyunfu clinicalsignificanceoftumornecrosisfactorainhibitorsinthetreatmentofsciaticaasystematicreviewandmetaanalysis
AT chenpingyou clinicalsignificanceoftumornecrosisfactorainhibitorsinthetreatmentofsciaticaasystematicreviewandmetaanalysis
AT changwei clinicalsignificanceoftumornecrosisfactorainhibitorsinthetreatmentofsciaticaasystematicreviewandmetaanalysis
AT zhufiqi clinicalsignificanceoftumornecrosisfactorainhibitorsinthetreatmentofsciaticaasystematicreviewandmetaanalysis
AT xulili clinicalsignificanceoftumornecrosisfactorainhibitorsinthetreatmentofsciaticaasystematicreviewandmetaanalysis
AT wangsonglin clinicalsignificanceoftumornecrosisfactorainhibitorsinthetreatmentofsciaticaasystematicreviewandmetaanalysis
AT changliying clinicalsignificanceoftumornecrosisfactorainhibitorsinthetreatmentofsciaticaasystematicreviewandmetaanalysis
AT luojie clinicalsignificanceoftumornecrosisfactorainhibitorsinthetreatmentofsciaticaasystematicreviewandmetaanalysis
AT liuguangjian clinicalsignificanceoftumornecrosisfactorainhibitorsinthetreatmentofsciaticaasystematicreviewandmetaanalysis